-
AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Business: Pharmaceuticals Retiring: John Leonard as SVP and CSO in the "next few months"
Published on 5/20/2013
-
Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Hired: David Apelian as EVP and CMO, formerly clinical director in the infectious diseases group at Bristol-Myers Squibb Co.; and Kevin…
Published on 5/20/2013
-
Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Pharmaceuticals Hired: Herbert Heitmann as head of communications and government relations, effective Sept. 1, currently EVP of external communications at Royal Dutch…
Published on 5/20/2013
-
Cynapsus Therapeutics Inc. (TSX:CTH), Toronto, Ontario Business: Drug delivery, Neurology Appointed: Tomer Gold, VP of R&D at Dexcel Pharma; and Ilan Oren, VP of business development at Dexcel
Published on 5/20/2013
-
CytoSorbents Corp., Monmouth Junction, N.J. Business: Infectious Hired: Kathleen Bloch as CFO, effective May 29, formerly CFO of Laureate Biopharmaceutical Services Inc.; she replaces Interim CFO Ronald Berger
Published on 5/20/2013
-
Egalet Ltd., Vaerlose, Denmark Business: Neurology, Cardiovascular, Drug delivery Hired: Stan Musial as CFO, a newly created position, formerly VP of finance and administration, treasurer, secretary and CFO of Prism …
Published on 5/20/2013
-
Genable Technologies Ltd., Dublin, Ireland Business: Ophthalmic, Gene/Cell therapy Appointed: Annette Clancy as chairman; she replaces John Monahan, who remains a non-executive director
Published on 5/20/2013
-
Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Business: Generics, Biosimilars Returned: Sumant Ramachandra as SVP of global R&D and regulatory and medical affairs and CSO; formerly president of R&D at Synta Pharmaceuticals…
Published on 5/20/2013
-
Immunocore Ltd., Abingdon, U.K. Business: Cancer, Endocrine/Metabolic, Infectious Hired: Eva-Lotta Allan as CBO, a newly created position, formerly CBO of Ablynx N.V.
Published on 5/20/2013
-
Innovotech Inc. (TSX-V:IOT), Edmonton, Alberta Business: Diagnostic Appointed: Kerry Brown as chairman; he replaces Wolfgang Muhs, who resigned
Published on 5/20/2013
-
IntelGenx Corp. (TSX-V:IGX; OTCBB:IGXT), Saint-Laurent, Quebec Business: Drug delivery Hired: Rajiv Khosla as CSO and COO, a newly created position, while stepping down as a director, formerly president and CEO of Orasi…
Published on 5/20/2013
-
Intra-Cellular Therapies Inc., New York, N.Y. Business: Neurology Appointed: Sir Michael Rawlins, former chairman of the U.K.'s NICE
Published on 5/20/2013
-
Kite Pharma Inc., Los Angeles, Calif. Business: Cancer Appointed: Farah Champsi, managing director at Alta Partners; and Ran Nussbaum, managing partner at Pontifax Ltd.
Published on 5/20/2013
-
Medivation Inc. (NASDAQ:MDVN), San Francisco, Calif. Business: Cancer Hired: Stephen Kelsey as SVP of new projects, a newly created position, formerly EVP of R&D and CMO of Geron Corp.
Published on 5/20/2013
-
NanoViricides Inc. (OTCBB:NNVC), West Haven, Conn. Business: Infectious Hired: Meeta Vyas as interim CFO
Published on 5/20/2013
-
Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio Business: Diagnostic Transitioned: EVP Thomas Tulip to president while remaining CBO; he replaces Mark Pykett, who remains CEO
Published on 5/20/2013
-
Opexa Therapeutics Inc. (NASDAQ:OPXA), The Woodlands, Texas Business: Autoimmune, Gene/Cell therapy Promoted: Don Healy to CSO from VP of manufacturing and scientific development; and Donna Rill to chief development …
Published on 5/20/2013
-
Optimer Pharmaceuticals Inc. (NASDAQ:OPTR), San Diego, Calif. Business: Infectious, Genitourinary, Cancer Hired: Eric Sirota as COO, formerly president of commercial services at inVentiv Health Inc.
Published on 5/20/2013
-
Pacgen Life Science Corp. (TSX-V:PBS), Vancouver, B.C. Business: Infectious, Pulmonary Transitioned: Chairman Chung-Yu Wang to interim CEO; he replaces Ming Liu, who stepped down and remains a director
Published on 5/20/2013
-
Relypsa Inc., Redwood City, Calif. Business: Endocrine/Metabolic Hired: John Orwin as CEO, effective by June 17, formerly CEO of Affymax Inc.; he succeeds Gerrit Kalerner, who remains a consultant
Published on 5/20/2013
-
TiGenix N.V. (Euronext:TIG), Leuven, Belgium Business: Musculoskeletal, Gene/Cell therapy Departed: Gil Beyen as managing director and CEO, while remaining a director; he is replaced by Eduardo Bravo
Published on 5/20/2013
-
Verastem Inc. (NASDAQ:VSTM), Cambridge, Mass. Business: Cancer Hired: John Green as CFO, formerly SVP and CFO of GTC Biotherapeutics Inc., which LFB S.A. acquired
Published on 5/20/2013
-
Zosano Pharma Inc., Fremont, Calif. Business: Drug delivery Hired: Nandan Oza as COO, formerly VP of chemistry, manufacturing and controls at Talon Therapeutics Inc.
Published on 5/20/2013
-
Ablynx N.V. (Euronext:ABLX), Ghent, Belgium Business: Antibodies Appointed: Russell Greig, formerly president of international pharmaceuticals and SVP of worldwide business development at GlaxoSmithKline plc; and Roger …
Published on 3/4/2013
-
Bausch + Lomb Inc., Rochester, N.Y. Business: Pharmaceuticals Hired: Robert Bertolini as president and CFO, formerly EVP and CFO of Schering-Plough Corp., which merged with Merck & Co. Inc.; he replaces Brian Harris
Published on 3/4/2013